Terns Pharmaceuticals Inc (TERN) Stock Price, Quote & News

Company Profile

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 525 5535

Fax: 650 275 4254

Website: www.ternspharma.com

Address:

1065 East Hillsdale Boulevard, Suite 100, Foster City, United States

Moneyme1 Dec. 13 at 10:09 PM

$TERN up 45% in one week! Not worried about a couple percent on Friday. If science stays confirmed, then the current price is cheap

0 · Reply

Moneyme1 Dec. 13 at 10:05 PM

$TERN wow! Been a member since yesterday!

0 · Reply

Whiskeyunderthebed Dec. 13 at 3:45 PM

$TERN https://www.onclive.com/view/tern-701-elicits-deep-responses-in-heavily-pretreated-cp-cml Have a listen:

0 · Reply

harmongreg Dec. 12 at 9:20 PM

Dragonfly Capital Premium Top 10 Equal Weighted gained a whopping 4.582% on the week using 100% of capital. Caught a positive pharma drug trial gain in $TERN. YTD +27.10%. https://dragonflycap.com/how-this-weeks-premium-top-10-performed-december-12-2025/

0 · Reply

Copperhead_Road Dec. 12 at 8:06 PM

$TERN beautiful dump. Nice green profits

0 · Reply

Copperhead_Road Dec. 12 at 7:30 PM

$TERN below 45.07 and this could dump. I'm short on this today from 46.30 so for today, take it down. Needs a pullback anyway.

0 · Reply

Foster_Todd_29 Dec. 12 at 6:57 PM

$TERN biotech with targeted pipeline, valuation hinges on upcoming data and partnership interest

0 · Reply

Gps_100X_ROI_Potential Dec. 12 at 6:47 PM

$SLS very rare to See STAT pumping any drug $TERN \ Similarities to 009 are many. https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/

2 · Reply

RMN1 Dec. 12 at 6:10 PM

$TERN .. Short Sell : Any amount more than 20 is definitely Win!!!! They played game to make public fool with fake price push and "offering at $40 "

2 · Reply

Copperhead_Road Dec. 12 at 5:51 PM

$TERN take this under 45 for the weekend

0 · Reply

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dec 9, 2025, 11:30 PM EST - 4 days ago

Terns Announces Pricing of Upsized $650 Million Public Offering

Dec 9, 2025, 3:31 PM EST - 4 days ago

Cancer Study Buoys These Small Biotechs

ACLX LEGN

Dec 9, 2025, 2:34 PM EST - 4 days ago

Terns Pharmaceuticals: CML Data Blows Wall Street Away - Again

Dec 9, 2025, 6:12 AM EST - 4 days ago

Terns Announces Proposed Public Offering

Dec 8, 2025, 11:27 PM EST - 5 days ago

Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript

$Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting$

Dec 8, 2025, 2:45 PM EST - 5 days ago

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

Dec 3, 2025, 9:11 AM EST - 10 days ago

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors

Nov 14, 2025, 4:05 PM EST - 4 weeks ago

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Nov 10, 2025, 4:05 PM EST - 4 weeks ago

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Nov 4, 2025, 4:05 PM EST - 5 weeks ago

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Nov 3, 2025, 1:05 PM EST - 5 weeks ago

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

$Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting$

Nov 3, 2025, 9:05 AM EST - 5 weeks ago

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Oct 22, 2025, 2:43 PM EDT - 7 weeks ago

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?

Oct 21, 2025, 4:56 PM EDT - 7 weeks ago

Terns Pharma ends obesity drug program after mid-stage trial data

Oct 21, 2025, 4:05 PM EDT - 7 weeks ago

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

Sep 21, 2025, 10:45 AM EDT - 2 months ago

2 Under-the-Radar Stocks That Could Soar

RYTM

Sep 10, 2025, 12:13 PM EDT - 3 months ago

Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 11:33 PM EDT - 3 months ago

Terns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar Transcript

Aug 21, 2025, 4:05 PM EDT - 4 months ago

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

Aug 6, 2025, 2:52 AM EDT - 4 months ago

Terns (TERN) Q2 Net Loss Narrows 16%

Aug 5, 2025, 4:05 PM EDT - 4 months ago

Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Jul 11, 2025, 11:27 AM EDT - 5 months ago

Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Jun 23, 2025, 4:07 PM EDT - 6 months ago

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

May 29, 2025, 4:05 PM EDT - 7 months ago

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

May 14, 2025, 9:30 AM EDT - 7 months ago

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

May 8, 2025, 4:05 PM EDT - 7 months ago

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Apr 30, 2025, 4:05 PM EDT - 8 months ago

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 2, 2025, 4:05 PM EDT - 9 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Mar 20, 2025, 4:05 PM EDT - 9 months ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Mar 9, 2025, 10:03 AM EDT - 9 months ago

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Feb 26, 2025, 4:05 PM EST - 10 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

Feb 25, 2025, 8:05 AM EST - 10 months ago

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

Feb 24, 2025, 4:05 PM EST - 10 months ago

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Feb 20, 2025, 4:05 PM EST - 10 months ago

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

Feb 5, 2025, 4:05 PM EST - 11 months ago

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 4:05 PM EST - 11 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Jan 8, 2025, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 1:18 PM EST - 1 year ago

Terns's stock soars as analysts cheer leukemia data — and predict more gains

Dec 3, 2024, 8:01 AM EST - 1 year ago

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial

Nov 19, 2024, 7:52 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In Q4

AMRN SLN

Nov 18, 2024, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

Nov 15, 2024, 11:19 AM EST - 1 year ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

AMGN LLY NVO VKTX

Sep 25, 2024, 10:30 AM EDT - 1 year ago

Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst

Sep 18, 2024, 10:07 AM EDT - 1 year ago

This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Sep 15, 2024, 7:21 AM EDT - 1 year ago

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Sep 14, 2024, 10:12 AM EDT - 1 year ago

1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More

Sep 13, 2024, 1:30 PM EDT - 1 year ago

Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic

ATLX BRZE DOCN EGO PL SLVM SMR

Sep 12, 2024, 7:00 PM EDT - 1 year ago

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 10, 2024, 10:50 PM EDT - 1 year ago

Terns Announces Pricing of Upsized $150.15 Million Public Offering

Moneyme1 Dec. 13 at 10:09 PM

$TERN up 45% in one week! Not worried about a couple percent on Friday. If science stays confirmed, then the current price is cheap

0 · Reply

Moneyme1 Dec. 13 at 10:05 PM

$TERN wow! Been a member since yesterday!

0 · Reply

Whiskeyunderthebed Dec. 13 at 3:45 PM

$TERN https://www.onclive.com/view/tern-701-elicits-deep-responses-in-heavily-pretreated-cp-cml Have a listen:

0 · Reply

harmongreg Dec. 12 at 9:20 PM

0 · Reply

Copperhead_Road Dec. 12 at 8:06 PM

$TERN beautiful dump. Nice green profits

0 · Reply

Copperhead_Road Dec. 12 at 7:30 PM

$TERN below 45.07 and this could dump. I'm short on this today from 46.30 so for today, take it down. Needs a pullback anyway.

0 · Reply

Foster_Todd_29 Dec. 12 at 6:57 PM

$TERN biotech with targeted pipeline, valuation hinges on upcoming data and partnership interest

0 · Reply

Gps_100X_ROI_Potential Dec. 12 at 6:47 PM

$SLS very rare to See STAT pumping any drug $TERN \ Similarities to 009 are many. https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/

2 · Reply

RMN1 Dec. 12 at 6:10 PM

$TERN .. Short Sell : Any amount more than 20 is definitely Win!!!! They played game to make public fool with fake price push and "offering at $40 "

2 · Reply

Copperhead_Road Dec. 12 at 5:51 PM

$TERN take this under 45 for the weekend

0 · Reply

Anthonyru445 Dec. 12 at 5:33 PM

$TERN I smell a lawsuit

1 · Reply

MoneyGroupLLC Dec. 12 at 5:24 PM

Enter: $TERN Calls Strike Price: $40 Expiry Date: JAN 16 2026 Buy in Price: $10.10 - $10.30 Sell Price: $14.85 Profit : +47% (Turn every $1 into $1.47) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

ILoseeverytime Dec. 12 at 5:23 PM

$ALT $TERN is only on phase 1 look at them!!! While ALT stuck at this price for 3 years!

2 · Reply

Copperhead_Road Dec. 12 at 5:12 PM

$TERN bear flag formed. Waititng to see what this does

0 · Reply

RMN1 Dec. 12 at 4:41 PM

$TERN BEST SHORT Sell Opportunity!!!! Look how systematically they planned to cheat individual investors!!! They hiked the price just to collect more money from public... It is still in phase-1 and don't know where it will go after FEW YEARS... It will be less than 10 in weeks / months!!!!!

0 · Reply

Copperhead_Road Dec. 12 at 4:27 PM

$TERN this has had a phenomenal run over the last 5 weeks. At some point, either a leveling out or dip is bound to occur

0 · Reply

kubota2323 Dec. 12 at 3:47 PM

$TERN welp

0 · Reply

Gutta123 Dec. 12 at 2:36 PM

$TERN

0 · Reply

TheHappyFlapjack Dec. 12 at 2:19 PM

$TERN 50 banger today if market is deep green

0 · Reply

Moneyme1 Dec. 12 at 1:57 PM

$TERN $50 + today! This is gearing up for a possible jump. If their results are what they have reported, this will be a ride for the stock and most importantly dreams being answered for the patients and families. I wish for the best for them first!

0 · Reply

Bullisch_150 Dec. 12 at 6:18 AM

$TERN bullisch Next: Let's take a guess at which big pharma will acquire Candel Therapeutics. I'm listing the companies with numbers; everyone's number is the one that will be acquired. 1) Merck 2) Pfizer 3) Novo Nordisk 4) Abbvie 5) Novartis 6) Eli Lilly 7) JJ 8) Roche 9) Amgen 10) Sanofi 11) GSK 12) Gilead 13) AstraZeneca

0 · Reply

BillionerOfKing Dec. 12 at 12:47 AM

$TERN Current Stock Price: $47.12 Contracts to trade: $45 TERN Dec 19 2025 Call Entry: $2.21 Exit: $4.15 ROI: 88% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Market Cap	4.05B
Revenue (ttm)	0.00
Net Income (ttm)	-88.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	6,876,100
Avg Vol	4,217,052
Day's Range	N/A - N/A
Shares Out	90.08M
Stochastic %K	86%
Beta	-0.24
Analysts	Strong Sell
Price Target	$53.55